SCHEMBL5512480

SCHEMBL5512480

CC(C)C[C@H](O[C@H](c1ccccc1)c1ccc(Br)cc1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
OPRM1 P35372 1/20 0.43
DRD3 P35462 1/20 0.43
SLC6A3 Q01959 1/20 0.43
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALDH1A1 P00352 1/20 0.41
FPR2 P25090 1/20 0.41
CTSK P43235 2/20 0.40
HTR2A P28223 1/20 0.39
CNR1 P21554 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5512484 1.00 CHRM2 (0.43) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL5520718 0.91 LMNA (0.43) LMNAALDH1A1MMP9MMELTA4H
SCHEMBL6170700 0.91 LMNA (0.43) LMNAALDH1A1MMP9MMELTA4H
SCHEMBL5516586 0.89 PPARG (0.48) LMNAALDH1A1FPR2CTSKCNR1
SCHEMBL5510848 0.89 FPR2 (0.39) SLC6A2SLC6A4SLC6A3LMNAFPR2
SCHEMBL6168522 0.89 PPARG (0.48) LMNAALDH1A1FPR2CTSKCNR1
SCHEMBL5516590 0.89 PPARG (0.48) LMNAALDH1A1FPR2CTSKCNR1
SCHEMBL5509570 0.88 KMT2A (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL6171510 0.88 IDO1 (0.48) ALDH1A1
SCHEMBL5509575 0.88 SLC6A2 (0.41) CHRM2HTR1AADRA2ACHRM1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279478-B2 Cathepsin cysteine protease inhibitors MERCK FROSST CANADA & CO. (CA) 2007-10-09 US disclosed
US-20060122268-A1 Cathepsin cysteine protease inhibitors MERCK CANADA INC. (CA) 2006-06-08 US disclosed
EP-1537074-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK FROSST CANADA INC. (CA) 2005-06-08 EP disclosed
WO-2004022526-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK FROSST CANADA & CO. (CA) 2004-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122268-A1 Cathepsin cysteine protease inhibitors CTSB, CTSS, CTSK CHRM2 4471/4885HTR1A 4520/4885ADRA2A 4655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.